| Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe) CY Ho, SM Day, EA Ashley, M Michels, AC Pereira, D Jacoby, AL Cirino, ... Circulation 138 (14), 1387-1398, 2018 | 616 | 2018 |
| Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy I Olivotto, F Girolami, MJ Ackerman, S Nistri, JM Bos, E Zachara, ... Mayo Clinic Proceedings 83 (6), 630-638, 2008 | 445 | 2008 |
| Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations F Girolami, CY Ho, C Semsarian, M Baldi, ML Will, K Baldini, F Torricelli, ... Journal of the American College of Cardiology 55 (14), 1444-1453, 2010 | 355 | 2010 |
| Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy I Olivotto, F Cecchi, R Gistri, R Lorenzoni, G Chiriatti, F Girolami, ... Journal of the American College of Cardiology 47 (5), 1043-1048, 2006 | 261 | 2006 |
| Genetic advances in sarcomeric cardiomyopathies: state of the art CY Ho, P Charron, P Richard, F Girolami, KY Van Spaendonck-Zwarts, ... Cardiovascular research 105 (4), 397-408, 2015 | 248 | 2015 |
| Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations I Olivotto, F Girolami, R Sciagrà, MJ Ackerman, B Sotgia, JM Bos, S Nistri, ... Journal of the American College of Cardiology 58 (8), 839-848, 2011 | 196 | 2011 |
| Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression P Di Donna, I Olivotto, SDL Delcre, D Caponi, M Scaglione, I Nault, ... Europace 12 (3), 347-355, 2010 | 178 | 2010 |
| Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations R Coppini, CY Ho, E Ashley, S Day, C Ferrantini, F Girolami, B Tomberli, ... Journal of the American College of Cardiology 64 (24), 2589-2600, 2014 | 165 | 2014 |
| The familial hypertrophic cardiomyopathy‐associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils A Belus, N Piroddi, B Scellini, C Tesi, GD Amati, F Girolami, M Yacoub, ... The Journal of physiology 586 (15), 3639-3644, 2008 | 139 | 2008 |
| Bioinformatics for next generation sequencing data A Magi, M Benelli, A Gozzini, F Girolami, F Torricelli, ML Brandi Genes 1 (2), 294-307, 2010 | 133 | 2010 |
| Novel α-actinin 2 variant associated with familial hypertrophic cardiomyopathy and juvenile atrial arrhythmias: a massively parallel sequencing study F Girolami, M Iascone, B Tomberli, S Bardi, M Benelli, G Marseglia, ... Circulation: Cardiovascular Genetics 7 (6), 741-750, 2014 | 98 | 2014 |
| Clinical spectrum, therapeutic options, and outcome of advanced heart failure in hypertrophic cardiomyopathy D Pasqualucci, A Fornaro, G Castelli, A Rossi, A Arretini, C Chiriatti, ... Circulation: Heart Failure 8 (6), 1014-1021, 2015 | 95 | 2015 |
| Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy E Biagini, I Olivotto, M Iascone, MI Parodi, F Girolami, G Frisso, C Autore, ... The American journal of cardiology 114 (5), 769-776, 2014 | 95 | 2014 |
| A molecular screening strategy based on β-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy F Girolami, I Olivotto, I Passerini, E Zachara, S Nistri, F Re, S Fantini, ... Journal of cardiovascular medicine 7 (8), 601-607, 2006 | 94 | 2006 |
| The many faces of hypertrophic cardiomyopathy: from developmental biology to clinical practice I Olivotto, F Girolami, S Nistri, A Rossi, L Rega, F Garbini, C Grifoni, ... Journal of cardiovascular translational research 2, 349-367, 2009 | 92 | 2009 |
| Long-term outcomes of pediatric-onset hypertrophic cardiomyopathy and age-specific risk factors for lethal arrhythmic events N Maurizi, S Passantino, G Spaziani, F Girolami, A Arretini, M Targetti, ... JAMA cardiology 3 (6), 520-525, 2018 | 86 | 2018 |
| Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy N Maurizi, V Rella, C Fumagalli, S Salerno, S Castelletti, F Dagradi, ... International Journal of Cardiology 300, 191-195, 2020 | 84 | 2020 |
| Contemporary genetic testing in inherited cardiac disease: tools, ethical issues, and clinical applications F Girolami, G Frisso, M Benelli, L Crotti, M Iascone, R Mango, ... Journal of Cardiovascular Medicine 19 (1), 1-11, 2018 | 74 | 2018 |
| Comparison of long‐term outcome in anthracycline‐related versus idiopathic dilated cardiomyopathy: a single centre experience A Fornaro, I Olivotto, L Rigacci, M Ciaccheri, B Tomberli, C Ferrantini, ... European Journal of Heart Failure 20 (5), 898-906, 2018 | 72 | 2018 |
| Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies F Mazzarotto, MH Hawley, M Beltrami, L Beekman, A De Marvao, ... Genetics in Medicine 23 (5), 856-864, 2021 | 71 | 2021 |
Francesca TorricelliHead of SOD Diagnostica Genetica, AOU Careggi, Firenze在 aou-careggi.toscana.it 的电子邮件经过验证
